Category

News Brief

FICS Research Expands Industry Partnerships, Workforce Development

The Florida Institute for Cybersecurity (FICS) Research is well-known and regarded as a global leader in hardware security and systems security research. FICS Research Director, Dr. Mark Tehranipoor, is generally acknowledged as the father of hardware security, in many cases having created the first programs, books, publications, and conferences in the domain.

Panbela Therapeutics, Inc. Completes Enrollment in Its Phase 1b Trial Investigating SBP-101 Combination Therapy for First-Line Metastatic Pancreatic Cancer

Panbela Therapeutics, Inc., formerly Sun Biopharma, a UF startup and clinical-stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has completed patient enrollment in its Phase 1 trial evaluating the safety and tolerability of SBP-101 when used in combination with standard of care agents gemcitabine and nab-paclitaxel for first-line treatment of patients with metastatic pancreatic ductal adenocarcinoma (PDA).

Uncovering How HLB Acts Inside a Citrus Tree

Amit Levy with the University of Florida Institute of Food and Agricultural Sciences (UF/IFAS) describes research he’s conducting into the way the causal agent of HLB interacts with a citrus tree. The causal agent is the bacterium Candidatus Liberibacter asiaticus(CLas).